Identification of an insulin-like growth factor-binding protein in human cerebrospinal fluid with a selective affinity for IGF-II.
Human cerebrospinal fluid (CSF) has been found to contain several different molecular forms of IGF-specific binding proteins (BPs). Qualitatively, they are similar to those present in serum, although their relative proportions are very different, as well as to those present in the culture media of brain tissue from which these BPs presumably arise. One particular form of BP is predominant in CSF. It has an Mr of 34,000, as estimated by SDS-polyacrylamide gel electrophoresis followed by transfer onto nitrocellulose, and an isoelectric point around 5.0 based on chromatofocusing. It has a selective affinity for IGF-II (approximately 4 X 10(10) M-1) as shown by competitive binding experiments in which biosynthetic IGF-I was about 40-times less potent than native IGF-II in displacing 125I-labelled IGF-II. These findings are in agreement with the preponderance of IGF-II in nervous tissue and in CSF and suggest that this BP plays an important role in the interaction of IGF-II with its target cells.
D002352:Carrier Proteins / Q000134:cerebrospinal fluid*; D006801:Humans; D007163:Immunosorbent Techniques; D007334:Insulin-Like Growth Factor I / Q000134:cerebrospinal fluid; D007335:Insulin-Like Growth Factor II / Q000134:cerebrospinal fluid / Q000378:metabolism*; D007526:Isoelectric Point; D008970:Molecular Weight; D013002:Somatomedins / Q000378:metabolism*
D002352:Carrier Proteins; D013002:Somatomedins; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II